Exploring avenues for best use of cytotechnologists in non‐gynaecological cytology: Double screening or independent sign‐out

Abstract

Double screening of NGC cases by two cytotechnologists prior to pathologist sign-out does not improve screening quality and is not cost-effective. The high concordance between the CTs and pathologists in this limited group of low complexity negative cases suggests that such cases could be signed out independently by cytotechnologists.